chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Arm hurt; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Arm hurt). The outcome of the pain in arm was resolved (duration 2 weeks).   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 23-MAR-2023 This case was reported by a patient via interactive digital media. The shot for shingles made patient arm hurt bad for two weeks. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Sore arm). The outcome of the pain in arm was resolved (duration 3 days).   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 23-MAR-2023 This case was reported by a patient via interactive digital media. The patient have to wait 3 months minimum between 1st dose and 2nd dose. The patient did her/his last summer and had no issues only a sore arm for 3 days. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: Hurt but worth it; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Hurt but worth it). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 23-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that, he/she did too. hurt but worth it. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: Feel kind of achy/some achiness; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 22-MAR-2023, the patient received the 2nd dose of Shingles vaccine. In MAR-2023, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Feel kind of achy/some achiness). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 23-MAR-2023 This case was reported by a patient via interactive digital media. The patient got second shot yesterday. The patient feel kind of achy but he/she would rather go through some achiness versus shingles. The patient stated that please get the shot. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal
Clinical narrative: I feel like crap, side effects; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 21-APR-2023, the patient received the 2nd dose of Shingles vaccine. On 21-APR-2023, less than a day after receiving Shingles vaccine, the patient experienced feeling bad (Verbatim: I feel like crap, side effects). The outcome of the feeling bad was not resolved.   It was unknown if the reporter considered the feeling bad to be related to Shingles vaccine.     It was unknown if the company considered the feeling bad to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 21-Apr-2023. The patient reported this case via interactive digital media. The patient had his/her final vaccine in morning on day of reporting, so now the ads were coming. The patient felt like crap at the time of reporting, hope the side effects go away soon.
Sex: U
Vaccine: VARZOS
Symptoms: Illness
Clinical narrative: Sick as a dog; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: Sick as a dog). The outcome of the sickness was not reported.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     It was unknown if the company considered the sickness to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 25-MAR-2023 This case was reported by a patient via interactive digital media. The patient got her/his first shingles shot, made her/him sick as a dog.  The patient won't be getting the second one. that's even stronger than the first. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 65-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 10-FEB-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal, Pain
Clinical narrative: Painful; Was down for a week; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Painful) and feeling bad (Verbatim: Was down for a week). The outcome of the pain was not reported and the outcome of the feeling bad was resolved (duration 1 week).   It was unknown if the reporter considered the pain and feeling bad to be related to Shingles vaccine.     It was unknown if the company considered the pain and feeling bad to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR060543   Additional Information: GSK Receipt date: 24-MAR-2023 This case was reported by a patient via interactive digital media. The shingle vaccine was soo painful patient was down for a week for both vaccine. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information. This case has been linked with case US2023AMR060543 reported by the same reporter; Sender's Comments:  US-GSK-US2023AMR060543:Same patient/same product
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal, Mobility decreased, Pain, Vaccine positive rechallenge
Clinical narrative: Painful; Was down for a week; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain (1st dose received on an unknown date refer case US2023AMR060540).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Painful) and feeling bad (Verbatim: Was down for a week). Rechallenge with Shingles vaccine was positive. The outcome of the pain was not reported and the outcome of the feeling bad was resolved (duration 1 week).   It was unknown if the reporter considered the pain and feeling bad to be related to Shingles vaccine.     It was unknown if the company considered the pain and feeling bad to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR060540   Additional Information: GSK Receipt date: 24-MAR-2023 This case was reported by a patient via interactive digital media. The shingle vaccine was soo painful patient was down for a week for both vaccine. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.; Sender's Comments:  US-GSK-US2023AMR060540:Same patient/same product
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 52-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 08-FEB-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 56-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 08-FEB-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 50-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 10-FEB-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 56-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 24-FEB-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: HIBV
Symptoms: Product storage error
Clinical narrative: Received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a patient who received Hib (Hiberix) (batch number 25Z52) for prophylaxis.   On 04-JAN-2023, the patient received Hiberix. On 04-JAN-2023, an unknown time after receiving Hiberix, the patient experienced incorrect storage of drug (Verbatim: Received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter US-GSK-US2023AMR060527:same reporter US-GSK-US2023AMR060523:same reporter US-GSK-US2023AMR060577:same reporter US-GSK-US2023AMR060588:same reporter US-GSK-US2023AMR060624:same reporter US-GSK-US2023AMR060616:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 76-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 16-FEB-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case was for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter US-GSK-US2023AMR060527:Original Case : US2023AMR056407 US-GSK-US2023AMR060523:Original Case : US2023AMR056407 US-GSK-US2023AMR060577:Original Case : US2023AMR056407 US-GSK-US2023AMR060588:Original Case : US2023AMR056407 US-GSK-US2023AMR060616:Original Case : US2023AMR056407 US-GSK-US2023AMR060629:Original Case : US2023AMR056407 US-GSK-US2023AMR060624:Original Case : US2023AMR056407
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 58-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 21-FEB-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case was for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter US-GSK-US2023AMR060527:Original Case : US2023AMR056407 US-GSK-US2023AMR060523:Original Case : US2023AMR056407 US-GSK-US2023AMR060577:Original Case : US2023AMR056407 US-GSK-US2023AMR060588:Original Case : US2023AMR056407 US-GSK-US2023AMR060624:Original Case : US2023AMR056407 US-GSK-US2023AMR060616:Original Case : US2023AMR056407 US-GSK-US2023AMR060629:Original Case : US2023AMR056407 US-GSK-US2023AMR060632:Original Case : US2023AMR056407
Sex: U
Vaccine: HIBV
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a infant patient who received Hib (Hiberix) (batch number 25Z52) for prophylaxis.   On 12-JAN-2023, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The patients age was reported as 0 years. The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter US-GSK-US2023AMR060527:Original Case : US2023AMR056407 US-GSK-US2023AMR060523:Original Case : US2023AMR056407 US-GSK-US2023AMR060577:Original Case : US2023AMR056407 US-GSK-US2023AMR060588:Original Case : US2023AMR056407 US-GSK-US2023AMR060616:Original Case : US2023AMR056407 US-GSK-US2023AMR060635:Original Case : US2023AMR056407 US-GSK-US2023AMR060624:Original Case : US2023AMR056407 US-GSK-US2023AMR060629:Original Case : US2023AMR056407 US-GSK-US2023AMR060632:Original Case : US2023AMR056407
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 72-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 20-FEB-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case was for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 56-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 24-FEB-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter US-GSK-US2023AMR060652:Original Case : US2023AMR056407
Sex: U
Vaccine: TDAP
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 1-year-old patient who received DTPa (DTPa vaccine) (batch number 9HP9Z) for prophylaxis.   On 19-JAN-2023, the patient received DTPa vaccine. On an unknown date, an unknown time after receiving DTPa vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter US-GSK-US2023AMR060653:Original Case : US2023AMR056407
Sex: U
Vaccine: DTAP
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 1-year-old patient who received DTPa (DTaP vaccine) (batch number 9HP9Z) for prophylaxis.   On 27-FEB-2023, the patient received DTaP vaccine. On an unknown date, an unknown time after receiving DTaP vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter US-GSK-US2023AMR060668:Original Case : US2023AMR056407 US-GSK-US2023AMR060653:Original Case : US2023AMR056407
Sex: U
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 56-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 20-FEB-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Feeling abnormal, Pyrexia
Clinical narrative: Have felt awful; Chills; Fever; Exhaustion; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feels awful in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced feels awful (Verbatim: Have felt awful), chills (Verbatim: Chills), fever (Verbatim: Fever) and exhaustion (Verbatim: Exhaustion). The outcome of the feels awful, chills, fever and exhaustion were not reported.   It was unknown if the reporter considered the feels awful, chills, fever and exhaustion to be related to Shingles vaccine.     It was unknown if the company considered the feels awful, chills, fever and exhaustion to be related to Shingles vaccine.   Additional Information: GSK receipt date: 26-MAR-2023 This case was reported by a patient via interactive digital media. The patient just had the first vaccine a couple of days ago and have felt awful, chills, fever and exhaustion. The patient hope it was worth it. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Sex: U
Vaccine: VARZOS
Symptoms: Illness
Clinical narrative: Sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: Sick). The outcome of the sickness was resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     It was unknown if the company considered the sickness to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 26-MAR-2023 This case was reported by a patient via interactive digital media. The patient just got the shot and he/she was a little sick but now better hope it's all worth it. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: Painful; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: Painful). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingrix.     It was unknown if the company considered the pain to be related to Shingrix.   Additional Information: GSK Receipt date: 26-MAR-2023 This case was reported by a patient via interactive digital media. The patient just got her/his shingrix shot and very painful. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: Hurt as bad; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Hurt as bad). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK receipt date: 26-MAR-2023 This case was reported by a patient via interactive digital media. The patient got the first of two shots on the ninth, hope the second shot don't hurt as bad as the first one. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Sex: U
Vaccine: VARZOS
Symptoms: Mobility decreased, Pain
Clinical narrative: It was so painful; I can't even move my arms; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: It was so painful) and mobility decreased (Verbatim: I can't even move my arms). The outcome of the pain and mobility decreased were resolved (duration 1 week).   It was unknown if the reporter considered the pain and mobility decreased to be related to Shingles vaccine.     It was unknown if the company considered the pain and mobility decreased to be related to Shingles vaccine.   Additional Information: GSK receipt date: 26-MAR-2023 This case was reported by a patient via interactive digital media. The patient had the shot but it was so painful.  The patient can't even move her/his arms and lasted for a week. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal, Herpes zoster
Clinical narrative: Mine are internal; Was on my deathbed; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Mine are internal) and feeling bad (Verbatim: Was on my deathbed). The outcome of the shingles was not reported and the outcome of the feeling bad was resolved.   It was unknown if the reporter considered the shingles and feeling bad to be related to Shingles vaccine.     It was unknown if the company considered the shingles and feeling bad to be related to Shingles vaccine.   Additional Information: GSK receipt date: 27-MAR-2023 This case was reported by a patient via interactive digital media. The patient stated that, misery, her/his are internal. The patient just took the first vaccine and was on her/his deathbed for over a week.  Not quite sure he/she will risk the second but patient don't want shingles again either. The follow-up could not be possible as no contact details were available. This report was one of several cases received as part of a line-listing, each containing minimal information.
Sex: U
Vaccine: TDAP
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 11-year-old patient who received DTPa (Reduced antigen) (Tdap Vaccine) (batch number 57GJ2) for prophylaxis.   On 13-JAN-2023, the patient received Tdap Vaccine. On an unknown date, an unknown time after receiving Tdap Vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case was for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: TDAP
Symptoms: Product storage error
Clinical narrative: Received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 57-year-old patient who received DTPa (Reduced antigen) (Tdap Vaccine) (batch number 397B5) for prophylaxis.   On 30-JAN-2023, the patient received Tdap Vaccine. On an unknown date, an unknown time after receiving Tdap Vaccine, the patient experienced incorrect storage of drug (Verbatim: Received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: TDAP
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 16-year-old patient who received DTPa (Reduced antigen) (Tdap Vaccine) (batch number 57GJ2) for prophylaxis.   On 24-JAN-2023, the patient received Tdap Vaccine. On an unknown date, an unknown time after receiving Tdap Vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case was for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: HEPA
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 19-year-old patient who received Hepatitis A vaccine (batch number 95DB2) for prophylaxis.   On 28-FEB-2023, the patient received Hepatitis A vaccine. On an unknown date, an unknown time after receiving Hepatitis A vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case was for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: TDAP
Symptoms: Product storage error
Clinical narrative: Received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 52-year-old patient who received DTPa (Reduced antigen) (Tdap Vaccine) (batch number 397B5) for prophylaxis.   On 30-JAN-2023, the patient received Tdap Vaccine. On an unknown date, an unknown time after receiving Tdap Vaccine, the patient experienced incorrect storage of drug (Verbatim: Received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Sex: U
Vaccine: TDAP
Symptoms: Product storage error
Clinical narrative: received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 61-year-old patient who received DTPa (Reduced antigen) (Tdap Vaccine) (batch number 397B5) for prophylaxis.   On 07-FEB-2023, the patient received Tdap Vaccine. On an unknown date, an unknown time after receiving Tdap Vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case was for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Age: 13.0
Sex: F
Vaccine: HEPA
Symptoms: Extra dose administered, Product administered to patient of inappropriate age
Clinical narrative: Adult dose inadvertently administered to a pediatric patient; Adult dose given to 13 years old; Extra Havrix administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of accidental overdose in a 13-year-old female patient who received HAV (Havrix adult) (batch number 55M72, expiry date 13-DEC-2024) for prophylaxis.   Previously administered products included Hepatitis A (the schedule completed in November 2011).   On 18-APR-2023, the patient received Havrix adult. On 18-APR-2023, an unknown time after receiving Havrix adult, the patient experienced accidental overdose (Verbatim: Adult dose inadvertently administered to a pediatric patient), adult product administered to child (Verbatim: Adult dose given to 13 years old) and extra dose administered (Verbatim: Extra Havrix administered). The outcome of the accidental overdose, adult product administered to child and extra dose administered were unknown.   Additional Information: GSK Receipt Date: 18-APR-2023 The nurse called to report an adult dose of Havrix was inadvertently administered to a pediatric patient. The reporter stated that an extra dose of Havrix was administered to a patient with an already complete schedule for Hepatitis A. The dose given was an adult dose reported. The patient completed the Hepatitis A schedule in November 2011, no specific vaccine reported. The reporter did not consent to follow-up. This case was identified as duplicate of US2023056791. Case US2023056791 was deleted and all the future correspondence will be added in the present case US2023056790 which stands as a case of record for this subject.
Age: 34.0
Sex: F
Vaccine: HEP
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: Adult patient was given a pediatric 10 microgram dose; Adult patient was given a pediatric 10 microgram dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of underdose in a 34-year-old female patient who received HBV (Engerix B pediatric) (batch number FB9RH, expiry date 21-JAN-2024) for prophylaxis.   On 18-APR-2023, the patient received the 1st dose of Engerix B pediatric 10 ug. On 18-APR-2023, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: Adult patient was given a pediatric 10 microgram dose) and adult use of a child product (Verbatim: Adult patient was given a pediatric 10 microgram dose). The outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK Receipt Date: 18-APR-2023 The nurse reported that an adult patient was given a pediatric 10 microgram dose of Engerix.  The event occurred in the healthcare professional's location/clinic. The reporter consented to follow up via email. The adult patient received a pediatric dose of Engerix, which led to underdose and adult use of a child product.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Feeling cold, Headache, Insomnia, Pyrexia
Clinical narrative: Feeling cold; Feverish; Headache; Sleeplessness; Fatigue; This non-serious case was reported by a consumer via call center representative and described the occurrence of feeling cold in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17-APR-2023, the patient received the 2nd dose of Shingrix. In APR-2023, an unknown time after receiving Shingrix, the patient experienced feeling cold (Verbatim: Feeling cold), fever (Verbatim: Feverish), headache (Verbatim: Headache), sleeplessness (Verbatim: Sleeplessness) and fatigue (Verbatim: Fatigue). The outcome of the feeling cold, fever, headache, sleeplessness and fatigue were unknown.   It was unknown if the reporter considered the feeling cold, fever, headache, sleeplessness and fatigue to be related to Shingrix.     It was unknown if the company considered the feeling cold, fever, headache, sleeplessness and fatigue to be related to Shingrix.   Additional Information: GSK Receipt Date: 18-APR-2023 The reporter reported that she received her second dose of Shingrix and had since experienced feeling cold, feverish, headache, sleeplessness, and fatigue. The reporter consented to follow up.
Age: 60.0
Sex: M
Vaccine: HEP
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: 60 YO received pediatric dose; 60 YO received pediatric dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 60-year-old male patient who received HBV (Engerix B pediatric) (batch number EP724, expiry date 14-MAR-2025) for prophylaxis.  On 18-APR-2023, the patient received the 1st dose of Engerix B pediatric. On 18-APR-2023, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: 60 YO received pediatric dose) and underdose (Verbatim: 60 YO received pediatric dose). The outcome of the adult use of a child product and underdose were unknown.  This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional Information: GSK Receipt Date: 18-APR-2023 A pharmacist technician reported that, the patient was injected with Engerix-B pediatric formulation as a first dose.  No other details such as patient´s date of birth or initials were available at the moment of the call. The reporter had denied consent to follow-up. The adult patient received the Engerix-B pediatric dose, which led to adult use of a child product and underdose.
Sex: M
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: 1st dose Oct2022, 2nd not yet; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in October 2022).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose Oct2022, 2nd not yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 18-APR-2023 The caller was the patient.  The patient had not yet received the second dose. The reporter did not consent to follow-up.     Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Sex: M
Vaccine: HEP
Symptoms: Incomplete course of vaccination
Clinical narrative: never received another dose to complete the schedule; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 36-year-old male patient who received HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix B (patient received only one dose of Engerix-b on July 2022 ).   On an unknown date, the patient did not receive Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced incomplete course of vaccination (Verbatim: never received another dose to complete the schedule). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 18-APR-2023. The pharmacist reported that a patient received only one dose of Engerix-B. The patient never received another dose to complete the schedule of Engerix B.  The reporter consented to follow up.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: shingles 4 days after 1st dose; This non-serious case was reported by a physician via sales rep and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 4 days after receiving Shingrix, the patient experienced shingles (Verbatim: shingles 4 days after 1st dose). The outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.     It was unknown if the company considered the shingles to be related to Shingrix.   Additional Information: GSK Receipt Date: 18-APR-2023 The reported enquired if the patients could get shingles after Shingrix vaccine.  The reporter enquired about when could patient receive second shot once developed shingles.